Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-release Paracetamol in Osteoarthritis
NCT02311881Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acetaminophen in osteoarthritis (OA) (3 arms), sponsored by GSK. Primary endpoint: Western Ontario McMaster (WOMAC) Pain at 12 weeks. Started Jan 2015; status: completed.
02
Drugs
acetaminophen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02311881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02311881.